Biopharmaceuticals Information Consulting Services (BICS)
Biopharmaceutical products are an important growth area for pharmaceutical and biotech companies. But this is a highly regulated and complex segment due to the nature of biopharmaceutical manufacturing. Even more importantly, there exists a shortage of manufacturing capacity. For those companies considering entry into or expansion of biopharmaceutical manufacturing, there is a legitimate concern that the current under-capacity situation may quickly become one of over-capacity. For marketers, there is a concern over the ability to meet future demand and understanding the competitive landscape that impacts their products. All companies looking at biopharmaceuticals need to develop strategies with fluctuating capacity utilization in mind.
BICS is designed to assist companies in answering such questions as:
For Fine Chemical Companies:
- What do we need to do to enter into this business?
- Should we become a contract manufacturer for biopharmaceuticals?
- Should we expand our capacity to manufacture biopharmaceuticals?
- Which companies are seeking manufacturers for clinical or commercial quantities?
- Are there alternative technologies under development to manufacture biopharmaceuticals?
- What is the likelihood that these alternative technologies will become commercial reality?
For Biotech Companies:
- Where can we find manufacturers to manufacture our product in clinical or commercial quantities?
- What is the competitive situation as to biopharmaceuticals under development for the same disease targets?
- Should we expand our capacity to manufacture biopharmaceuticals?
- Are there alternative technologies under development to manufacture biopharmaceuticals?
- What is the likelihood that these alternative technologies will become commercial reality?
